Related Experiment Video
Updated: Feb 4, 2026

A Porcine Model of Acute Autologous Pulmonary Embolism
Published on: September 6, 2024
Heparin-Induced Thrombocytopenia in a Patient With Postoperative Pulmonary Embolism: D-dimer Re-elevation and
Satoshi Kurisu1, Hitoshi Fujiwara1, Yutaka Tanaka2
1Department of Cardiology, National Hospital Organization Hiroshima Nishi Medical Center, Otake, JPN.
Abstract:
Heparin-induced thrombocytopenia (HIT) is a rare but serious immune-mediated complication of heparin therapy, characterized by thrombocytopenia and paradoxical thrombosis. We report a case of HIT in an 83-year-old woman who developed postoperative pulmonary embolism (PE). Continuous unfractionated heparin was initiated, leading to initial improvement. However, seven days after PE and heparin initiation, thrombocytopenia and D-dimer re-elevation occurred without new symptoms. Her 4Ts score was 7, prompting a switch from heparin to argatroban. HIT antibodies were subsequently confirmed, and computed tomography (CT) revealed a new thrombus in the main pulmonary artery. Argatroban was later replaced with edoxaban after platelet recovery. Both thrombocytopenia and D-dimer levels gradually improved, and the patient was discharged 30 days after PE onset. Outpatient follow-up CT confirmed complete thrombus resolution. Clinicians should maintain a high index of suspicion for HIT in heparin-treated patients presenting with thrombocytopenia, with supportive laboratory findings such as unexpected D-dimer elevation, even in the absence of new or worsening symptoms. Early recognition and prompt management are essential to improve outcomes and prevent severe complications or death.
More Related Videos
07:02A Large Animal Model for Pulmonary Hypertension and Right Ventricular Failure: Left Pulmonary Artery Ligation and Progressive Main Pulmonary Artery Banding in Sheep
Published on: July 15, 2021
10:03Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension
Published on: June 27, 2025
Related Concept Videos
Pulmonary Embolism I: Introduction
Pulmonary Embolism III: Nursing Management
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...